Prevalence in vivo maturation of human oocytes for conventional IVF-ET

被引:0
|
作者
Matsunami, K [1 ]
Furui, T [1 ]
Imai, A [1 ]
Takagi, H [1 ]
Noda, K [1 ]
Tamaya, T [1 ]
机构
[1] Matsunami Gen Hosp, Dept Obstet & Gynecol, Gifu, Japan
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Optimal interval between hCG administration and oocyte retreaval in IVF-ET was assessed. Subjects included women (n=60) undergoing follicular stimulation for IVF-ET, with using long- or short-courses of GnRH agonist regimen to suppress endogenous LH. They were submitted at random to a short (34 hours) or a long (39 hours) delay between hCG administration and oocyte retrieval. Each patient's oocytes were inseminated immediately in a long delay or 5 hours after in vitro maturation in a short delay; no unexpected ovulation occurred before oocyte retreaval throughout the study. Insemination immediately after a short hCG/oocyte retrieval interval (5.41%) protected the polyspermic fertilization, compared to oocytes preincubated before insemination (7.24%). A short hGG/oocyte retrieval interval significantly reduced this polyspermic fertilization incidence (p<0.05). Fertilization rates were higher with 39 hr (82.2%) than with 34 hr (75.2%) in vivo maturation (P < 0.05). Extending the hCG/oocyte retrieval interval (3.9%) reduced the incidence of delayed fertilization (12.9%). Pregnancy rates per ET were higher with 3 9 hr (30.2%) than with 34 hr (23.1%) in vivo maturation (P < 0.05). These findings led us to the conception that prolonged oocyte maturation interval up to 39 hours resulted in prevalent fertilization rates, and improved the required interval for presemination. These findings may permit the simple, safe and time-spared laboratory procedures.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 50 条
  • [21] IVF-ET WOMEN AGED OVER 39
    GUICHARD, A
    BRAMI, C
    BOYER, P
    EPELBOIN, S
    JANSSENS, Y
    JOSSERAND, S
    NATHAN, C
    PEREZ, J
    SAVALE, M
    ZORN, JR
    [J]. CONTRACEPTION FERTILITE SEXUALITE, 1991, 19 (7-8): : 570 - 571
  • [22] ICSI AS ANOTHER METHOD IN IVF-ET TREATMENT
    BEIER
    DIEDRICH
    THAELE
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1995, 55 (09) : R14 - R16
  • [23] Outcome of heterotopic pregnancy following IVF-ET
    Chen, H.
    Han, J. L.
    Peng, X. D.
    Yan, J. M.
    [J]. HUMAN REPRODUCTION, 2010, 25 : I110 - I110
  • [24] Rescue in vitro maturation using ovarian support cells of human oocytes from conventional stimulation cycles yields oocytes with improved nuclear maturation and transcriptomic resemblance to in vivo matured oocytes
    Paulsen, Bruna
    Piechota, Sabrina
    Barrachina, Ferran
    Giovannini, Alexa
    Kats, Simone
    Potts, Kathryn S.
    Rockwell, Graham
    Marchante, Maria
    Estevez, Samantha L.
    Noblett, Alexander D.
    Figueroa, Alexandra B.
    Aschenberger, Caroline
    Kelk, Dawn A.
    Forti, Marcy
    Marcinyshyn, Shelby
    Wiemer, Klaus
    Sanchez, Marta
    Belchin, Pedro
    Lee, Joseph A.
    Buyuk, Erkan
    Slifkin, Rick E.
    Smela, Merrick Pierson
    Fortuna, Patrick R. J.
    Chatterjee, Pranam
    Mcculloh, David H.
    Copperman, Alan B.
    Ordonez-Perez, Daniel
    Klein, Joshua U.
    Kramme, Christian C.
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2024, 41 (08) : 2021 - 2036
  • [25] NEVER ON A SUNDAY - PROGRAMMING FOR IVF-ET AND GIFT
    ZORN, JR
    BOYER, P
    GUICHARD, A
    [J]. LANCET, 1987, 1 (8529): : 385 - 386
  • [26] IVF-ET program at Beijing Medical University
    Zhang, LZ
    [J]. CHINESE MEDICAL JOURNAL, 1996, 109 (01) : 33 - 34
  • [27] Effects of Triggering Oocytes Maturation by rhCG 250 μg vs uhCG 10 000 IU on the Outcomes of IVF-ET Treatment in Chinese Population:A Cohort Study
    Rui YANG
    Rong LI
    Ping LIU
    Xin-na CHEN
    Cai-hong MA
    Jie QIAO
    [J]. Journal of Reproduction and Contraception, 2013, (01) : 21 - 29
  • [28] Prognostic implication of apoptosis in human luteinized granulosa cells during IVF-ET
    Suh, CS
    Jee, BC
    Choi, YM
    Kim, JG
    Lee, JY
    Moon, SY
    Kim, SH
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2002, 19 (05) : 209 - 214
  • [30] ANEUPLOIDY RATES ARE UNAFFECTED BY CHOICE OF TRIGGER MEDICATION IN HUMAN IVF-ET CYCLES
    Hernandez-Nieto, C. A.
    Nazem, T. G.
    Lee, J. A.
    Luna, M.
    Copperman, A. B.
    Sandler, B.
    [J]. FERTILITY AND STERILITY, 2017, 108 (03) : E223 - E224